Back to Search
CAROL AGHAJANIAN, MD
MD
Medical Oncology Physician
NPI: 1275570533IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
184036(NY)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
STATE UNIVERSITY OF NY UPSTATE MEDICAL UNIVERSITY
Class of 1989
Research & Publications (20)
Phase I study of the novel epothilone analog ixabepilone (BMS-247550) in patients with advanced solid tumors and lymphomas.
PMID 17261851·J Clin Oncol·2007
3-trial
Phase I trial of bortezomib and carboplatin in recurrent ovarian or primary peritoneal cancer.
PMID 16135465·J Clin Oncol·2005
3-trial
A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies.
PMID 12171876·Clin Cancer Res·2002
3-trial
Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash.
PMID 19162309·Gynecol Oncol·2009
3-trial
Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies.
PMID 19254808·Gynecol Oncol·2009
8-other
Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
PMID 19110302·Gynecol Oncol·2009
8-other
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.
PMID 19395008·Gynecol Oncol·2009
8-other
Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study.
PMID 19135708·Gynecol Oncol·2009
3-trial
Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer.
PMID 19019418·Gynecol Oncol·2009
8-other
A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer.
PMID 18554700·Gynecol Oncol·2008
3-trial
A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma.
PMID 18755503·Gynecol Oncol·2008
8-other
A phase I trial of pemetrexed plus gemcitabine given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer.
PMID 18829514·Clin Cancer Res·2008
3-trial
Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission.
PMID 18451240·Clin Cancer Res·2008
3-trial
Prognostic factors for patients with stage IV epithelial ovarian cancer receiving intraperitoneal chemotherapy after second-look assessment: results of long-term follow-up.
PMID 18428210·Cancer·2008
8-other
A phase 2 trial of oral imatinib in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma in second or greater remission.
PMID 19115680·Eur J Gynaecol Oncol·2008
3-trial
The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer.
PMID 18063020·Gynecol Oncol·2008
8-other
Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer.
PMID 17634545·Clin Cancer Res·2007
8-other
A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission.
PMID 17918264·Cancer·2007
3-trial
Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less.
PMID 17971592·J Clin Oncol·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (212) 639-2000
Quick Facts
- NPI
- 1275570533
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile